Cargando…
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
Drug interactions with other drugs are a well-known phenomenon. Similarly, however, pre-existing drug therapy can alter the course of diseases for which it has not been prescribed. We performed network analysis on drugs and their respective targets to investigate whether there are drugs or targets w...
Autores principales: | Schöning, Verena, Hammann, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504398/ https://www.ncbi.nlm.nih.gov/pubmed/36145576 http://dx.doi.org/10.3390/pharmaceutics14091828 |
Ejemplares similares
-
Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern
por: Schöning, Verena, et al.
Publicado: (2022) -
Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital
por: Schöning, Verena, et al.
Publicado: (2021) -
Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021) -
Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study
por: Schöning, Verena, et al.
Publicado: (2022) -
Modeling Structure–Activity Relationship of AMPK Activation
por: Drewe, Jürgen, et al.
Publicado: (2021)